Editas Medicine(us:EDIT)

    1.25

    -4.58%

    Updated on 2024-12-23

    Open:1.31
    Close:1.25
    High:1.34
    Low:1.25
    Pre Close:1.31
    Volume:2.03M
    Amount:2.59M
    Turnover:2.46%
    Shares:82.55M
    MarketCap:103.19M
    Total 2 records
    codechangetotalincreasedecreaserps5rps10rps15rps20

    Biote...

    BK2069

    +0.60%67230535331142442

    Gene ...

    BK2569

    +0.82%102712721

    About

    Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
    Address:11 Hurley Street

    Market Movers